Trintellix and Advil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Advil (ibuprofen). Common drug interactions include anxiety disorder among females and dyskinesia among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Advil. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Advil?

Advil has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 62,533 Advil users. Check the latest studies of Advil.



On Jul, 13, 2026

60 people who take Trintellix and Advil together, and have interactions are studied.

Trintellix and Advil drug interactions.

What are the common drug interactions of Trintellix and Advil, by gender? *:

female:

  1. Anxiety disorder
  2. Back pain
  3. Balance disorder
  4. Blood cholesterol decreased
  5. Body dysmorphic disorder (type of mental illness)
  6. Cough
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Disturbance in attention
  9. Dyspnoea (difficult or laboured respiration)
  10. Dysuria (painful or difficult urination)

male:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Abdominal discomfort
  3. Fatigue (feeling of tiredness)
  4. Food poisoning (poison in food)
  5. Hypersomnia (excessive daytime sleepiness (eds))
  6. Inflammation
  7. Joint injury
  8. Loss of consciousness
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Trintellix and Advil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Anxiety disorder
  4. Back pain
  5. Blood cholesterol decreased
  6. Body dysmorphic disorder (type of mental illness)
  7. Constipation
  8. Cough
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Disturbance in attention

30-39:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Drug ineffective
  4. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  5. Ocular hyperaemia (an abnormally large amount of blood in eye)
  6. Throat tightness
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Vision blurred

40-49:

n/a

50-59:

  1. Fatigue (feeling of tiredness)
  2. Alcohol abuse
  3. Loss of consciousness
  4. Self esteem decreased (self worth reduced)
  5. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  6. Infusion related reaction
  7. Suicidal ideation
  8. Weight increased
  9. Asthenia (weakness)
  10. Burning mouth syndrome (pain in the mouth and burning sensation on tongue)

60+:

  1. Pruritus (severe itching of the skin)
  2. Fatigue (feeling of tiredness)
  3. Dizziness
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypersensitivity
  7. Hypertension (high blood pressure)
  8. Infection
  9. Irritability
  10. Large intestine perforation (hole in large intestine)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 25 people, 41.67%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 22 people, 36.67%
  3. Stress And Anxiety: 10 people, 16.67%
  4. Drowsiness: 7 people, 11.67%
  5. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 6.67%
  6. Primary Immunodeficiency Syndrome: 3 people, 5.00%
  7. Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 5.00%
  8. Immunodeficiency Common Variable: 3 people, 5.00%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Advil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Advil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Advil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Advil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and ibuprofen (the active ingredients of Trintellix and Advil, respectively), and Trintellix and Advil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: